Filing Details

Accession Number:
0001209191-19-049089
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-10 19:10:44
Reporting Period:
2019-09-06
Accepted Time:
2019-09-10 19:10:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379344 Laurent Fischer C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-06 1,720 $10.71 1,720 No 4 P Direct
Common Stock Acquisiton 2019-09-09 1,670 $10.54 3,390 No 4 P Direct
Common Stock Acquisiton 2019-09-09 300 $11.30 3,690 No 4 P Direct
Common Stock Acquisiton 2019-09-10 960 $10.29 4,650 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The weighted average purchase price for the transaction reported was $10.7147, and the range of prices were between $10.50 and $10.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. The weighted average purchase price for the transaction reported was $10.54, and the range of prices were between $10.13 and $11.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  3. The weighted average purchase price for the transaction reported was $10.2932, and the range of prices were between $9.91 and $10.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.